Hydroxycarbamide Therapy Should Become The Standard Treatment For All Children With Sickle Cell Disease (Baby Hug Trial)

Links shared publicly online about this topic.

  • 282
    total visits

Hydroxycarbamide Therapy Should Become The Standard Treatment For All Children With Sickle Cell Disease (Baby Hug Trial)

medicalnewstoday.com —

The first randomised double-blind trial to examine the effect of hydroxycarbamide (previously hydroxyurea) in very young children with sickle-cell anaemia shows that the drug is safe and significa

View full resource at medicalnewstoday.com

Tags: Sickle-Cell Anemia, Disease and Condition, Drug, Children's Health, disease, Safety

  • Share

Most Recently Shared on May 19, 2011 at 9:05 pm By:

mnt_pediatrics MNT Pediatrics News

Hydroxycarbamide Therapy Should Become The Standard Treatment For All Children With Sickle Cell Disease (Baby Hug Trial) http://mnt.to/3W6H

11 months ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Infect Diseases MNT Infect Diseases

Advertisement